Page 642 - medicina-integrativa_compress

652 PARTE II, SECCIÓN 10 UROLOGÍA

comenzar con polen de centeno ■ Técnicas biomecánicas
(Cernilton ), 126 mg 3 veces al día.
®
• Recomendar baños de asiento diarios
según sea necesario y masajes prostáticos B B 1
periódicos.
■ Fármacos
• Probar un ciclo de 2-4 semanas con un
inhibidor de la COX-2 para aliviar los B B 2 2 ■ Índice de síntomas de prostatitis
síntomas de una prostatitis dolorosa.
Cuando se sospechan espasmos • Vigilar la respuesta terapéutica pidiendo a
musculares, probar un ensayo de 4-6 los pacientes que cumplimenten un índice
semanas con un antagonista de síntomas de prostatitis antes de iniciar
alfaadrenérgico; si se produce mejoría, el tratamiento y de forma mensual a partir
continuar con la medicación; en caso de entonces mientras persistan los
contrario, interrumpirla. síntomas (fig. 60-1).

BIBLIOGRAFÍA 19. Buck AC: Phytotherapy for the prostate. Br J Urol 78:325-336,
1996.
1. Schaeffer AJ, Landia JR, Knauss JS, et al: Demographic and clinical 20. Rugendorff EW, Weidner W, Ebeling I, Buck AC: Results of
characteristics of men with chronic prostatitis: The National treatment with pollen extract (Cernilton N) in chronic prostatitis
Institutes of Health Chronic Prostatitis Cohort Study. J Urol and prostodynia. Br J Urol 71:433-438, 1993.
168:593-598, 2002. 21. Wilt T, Ishani A, Mac Donald R, et al: Beta-sitosterols for benign
2. Krieger JN, Nyberg LJ, Nickel JC: NIH consensus definition and prostatic hyperplasia. Cochrane Database Syst Rev 1999
classification of prostatitis. JAMA 282:236-237, 1999. (3)CD001043, 1999.
3. Nickel JC: Prostatitis and related conditions. In Walsh PC, Retik AB, 22. Gruenwald J (ed): PDR for Herbal Medicines, 3rd ed. Montvale, NJ,
Vaughan ED Jr, et al (eds): Campbell’s Urology, 8th ed. Thomsom PDR, 2004, pp 792-797.
Philadelphia, WB Saunders, 2002, pp 603-630. 23. Avorn J, Monane M, Gurwitz JH, et al: Reduction of bacteriuria
4. Nickel JC: The Prostatitis Manual. Chipping Norton, UK, Blandon and pyuria after ingestion of cranberry juice. JAMA 271:751-754,
Medical, 2002, pp 1-116. 1994.
5. Fair WR, Couch J, Wehner N: Prostatic antibacterial factor: Identity 24. Jepson RG, Mihaljevic L, Craig J: Cranberries for preventing
and significance. Urology 7:169-177, 1976. urinary tract infections. Cochrane Database Syst Rev (2)CD001321,
6. Nickel JC, MacLean RJL: Bacterial biofilms in urology. Infect Urol 2004.
11:168-175, 1998. 25. Blumenthal M (ed): The Complete German Commission E
7. Shoskes DA, Thomas KD, Gomez E: Anti-nanobacterial therapy for Monographs: Therapeutic Guide to Herbal Medicines. Austin, Tex,
men with chronic prostatitis/chronic pelvic pain syndrome and American Botanical Council, 1998, pp 224-225.
prostatic stones: Preliminary experience. J Urol 173:474-477, 2005. 26. Mills SY: The Essential Book of Herbal Medicine. New York, Arkana
8. Hua VH, Williams DH, Schaeffer AJ: Role of bacteria in chronic Penguin Books, 1993, p. 470.
prostatitis/chronic pelvic pain syndrome. Current Prostate Reports 27. Guenze H, Langosch J, Schirrmacher K, et al: Kava pyrones
3:87-93, 2005. exert effects on neuronal transmission and transmembraneous
9. Pontari MA, Ruggieri MR: Mechanisms in prostatitis/chronic pelvic cation currents similar to established mood stabilizers—a review.
pain syndrome. J Urol 172:839-845, 2004. Prog Neuropsychopharmacol Biol Psychiatry 25:1555-1570,
10. Hetrick DC, Ciol MA, Rothman I, et al: Musculoskeletal dysfunction 2001.
in men with chronic pelvic pain syndrome type III: A case-control 28. Nichel JC, Narayan P, McKay J, et al: Treatment of chronic
study. J Urol 170:828-831, 2003. prostatitis/chronic pelvic pain syndrome with tamsulosin:
11. Nickel JC: Chronic bacterial prostatitis: An evolving clinical enigma. A randomized double-blind trial. J Urol 171:1594-1597, 2004.
Urology 66:2-8, 2005. 29. Alexander RB, Propert KJ, Schaeffer AJ, et al: Ciprofloxacin or
12. McClure MW: Smart Medicine for a Healthy Prostate: Natural and tamsulosin in men with chronic prostatitis/chronic pelvic pain
Conventional Therapies for Common Prostate Disorders. New York, syndrome: A randomized, double-blind trial. Ann Intern Med
Avery, 2001, p 66. 141:581-589, 2004.
13. Ho E, Boileau TW, Bray TM: Dietary influences on endocrine- 30. Nickel JC, Downey J, Clark J, et al: Levofloxacin for chronic
inflammatory interactions in prostate cancer development. Arch prostatitis/chronic pelvic pain syndrome in men: A randomized
Biochem Biophys 428:109-117, 2004. placebo-controlled multicenter trial. Urology 62:614-617, 2003.
14. Castle EP, Thrasher JB: The role of soy phytoestrogens in prostate 31. Nickel JC, Downey J, Hennenfent B: Repetitive prostatic massage
cancer. Urol Clin North Am 29:71-81, 2002. therapy for chronic refractory prostatitis: The Philippine experience.
15. Jellin JM (ed): Pharmacist’s Letter/Prescriber’s Letter Natural Tech Urol 5:146-151, 1999.
Medicines Comprehensive Database, 7th edition. Stockton, Calif, 32. Zermann DH, Ishigooka M, Doggweiler-Wiygul R, et al:
Therapeutic Research Faculty, 2005. The male chronic pelvic pain syndrome. World J Urol 19:173-179,
16. Shoskes DA, Zeitlin SI, Shahed A, Rajfer J: Quercetin in men with 2001.
category III chronic prostatitis: A preliminary prospective, 33. Clemens JQ, Nadler RB, Schaeffer AJ, et al: Biofeedback, pelvic floor
double-blind, placebo-controlled trial. Urology 54:960-963, 1999. re-education, and bladder training for male chronic pelvic pain
17. Pizzorno JE Jr, Murray MT: Flavonoids—quercetin, citrus syndrome. Urology 56:951-955, 2000.
flavonoids, and HERs (hydroxyethylrutosides). In Pizzorno JE Jr, 34. Anderson RU, Wise D, Sawyer T, et al: Integration of myofascial
Murray, MT (eds): Textbook of Natural Medicine, 2nd ed. St. Louis, trigger point release and paradoxical relaxation training treatment of
Churchill Livingstone, 1999, p 749. chronic pelvic pain in men. J Urol 174:155-160, 2005.
18. Vela-Navarrete R, Escribano-burgos M, Farrè AL, et al: Serenoa 35. Sahin A, Eiley D, Goldfischer ER, et al: The in vitro bactericidal
repens treatment modifies bax/bcl-2 index expression and caspase-3 effect of microwave energy on bacteria that cause prostatitis.
activity in prostatic tissue from patients with benign prostatic Urology 52: 411-416, 1998.
hyperplasia. J Urol 173:507-510, 2005. 36. Wenninger K, Heiman JR, Rothman I, et al: Sickness impact